Shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) have been assigned a consensus recommendation of “Buy” from the fourteen ratings firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $25.10.

KTWO has been the subject of a number of recent research reports. Royal Bank Of Canada reissued a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research report on Thursday, July 20th. BidaskClub raised K2M Group Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, July 19th. Cowen and Company reissued a “buy” rating and issued a $26.00 target price on shares of K2M Group Holdings in a research report on Wednesday, July 19th. Oppenheimer Holdings, Inc. reissued a “buy” rating on shares of K2M Group Holdings in a research report on Tuesday, July 11th. Finally, Zacks Investment Research raised K2M Group Holdings from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a research report on Wednesday, October 4th.

COPYRIGHT VIOLATION NOTICE: “K2M Group Holdings, Inc. (KTWO) Given Consensus Recommendation of “Buy” by Analysts” was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/10/26/k2m-group-holdings-inc-ktwo-given-consensus-recommendation-of-buy-by-analysts.html.

K2M Group Holdings (NASDAQ KTWO) opened at 19.82 on Thursday. The company’s market capitalization is $857.57 million. K2M Group Holdings has a 52 week low of $16.32 and a 52 week high of $25.99. The stock’s 50 day moving average price is $20.84 and its 200 day moving average price is $22.45.

K2M Group Holdings (NASDAQ:KTWO) last released its earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The business had revenue of $65.70 million during the quarter, compared to the consensus estimate of $66.26 million. During the same period last year, the business posted ($0.27) earnings per share. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Analysts anticipate that K2M Group Holdings will post ($0.84) earnings per share for the current year.

In related news, CFO Gregory S. Cole sold 39,357 shares of K2M Group Holdings stock in a transaction on Friday, August 11th. The stock was sold at an average price of $23.37, for a total transaction of $919,773.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Gregory S. Cole sold 2,350 shares of K2M Group Holdings stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $56,588.00. Following the sale, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at approximately $1,328,204.64. The disclosure for this sale can be found here. Insiders have sold 44,129 shares of company stock valued at $1,033,644 in the last three months. 5.80% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of KTWO. TimesSquare Capital Management LLC boosted its stake in K2M Group Holdings by 31.5% during the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after buying an additional 691,000 shares during the period. Point72 Asset Management L.P. boosted its stake in K2M Group Holdings by 114.0% during the first quarter. Point72 Asset Management L.P. now owns 555,500 shares of the medical device company’s stock valued at $11,393,000 after buying an additional 295,900 shares during the period. Prudential Financial Inc. bought a new stake in K2M Group Holdings during the second quarter valued at $6,595,000. Artemis Investment Management LLP boosted its stake in K2M Group Holdings by 255.4% during the second quarter. Artemis Investment Management LLP now owns 316,703 shares of the medical device company’s stock valued at $7,716,000 after buying an additional 227,582 shares during the period. Finally, State Street Corp boosted its stake in K2M Group Holdings by 39.8% during the second quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock valued at $17,378,000 after buying an additional 203,067 shares during the period. 98.88% of the stock is owned by institutional investors.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.